KELLY STUBBLEFIELD: Open Payments
NPI 1598877953 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 60 payments from 15 companies in 2025. Trend: 2023 $556 · 2024 $838 · 2025 $1,491
Food & beverage: $1,391Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $374 |
| Janssen Biotech, Inc. | 9 | $256 |
| UCB, Inc. | 8 | $249 |
| Galderma Laboratories, L.P. | 8 | $154 |
| GENZYME CORPORATION | 4 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Lilly USA, LLC | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, RINVOQ, BOTOX, DUPIXENT, SKYRIZI, EBGLYSS.
Industry payments across FL — which companies pay providers there.
